Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-05-06 | PALISADE BIO, INC. | Jones Mitchell La...
(CEO, CFO, Director) |
M | Common Stock, par value $0.01 | A | 460 | $0.00 - $0.00 | $0 |
2024-05-06 | PALISADE BIO, INC. | Jones Mitchell La...
(CEO, CFO, Director) |
F | Common Stock, par value $0.01 | D | 137 | $8.46 - $8.46 | $1,158 |
2024-05-06 | PALISADE BIO, INC. | Finley John David
(CEO, CFO, Director) |
M | Common Stock, par value $0.01 | A | 443 | $0.00 - $0.00 | $0 |
2024-05-06 | PALISADE BIO, INC. | Finley John David
(CEO, CFO, Director) |
F | Common Stock, par value $0.01 | D | 128 | $8.46 - $8.46 | $1,082 |
2024-03-11 | PALISADE BIO, INC. | Finley John David
(CEO, CFO, Director) |
M | Common Stock, par value $0.01 | A | 5558 | $0.00 - $0.00 | $0 |
2024-02-09 | PALISADE BIO, INC. | Neal James R
(Director) |
M | Common Stock, par value $0.01 | A | 10920 | $0.00 - $0.00 | $0 |
2024-02-08 | PALISADE BIO, INC. | Csimma Cristina
(Director) |
M | Common Stock, par value $0.01 | A | 12800 | $0.00 - $0.00 | $0 |
2024-02-08 | PALISADE BIO, INC. | Trenschel Robert J.
(Director) |
M | Common Stock, par value $0.01 | A | 10920 | $0.00 - $0.00 | $0 |
2024-02-08 | PALISADE BIO, INC. | Diaz Stephanie
(Director) |
M | Common Stock, par value $0.01 | A | 12800 | $0.00 - $0.00 | $0 |
2024-02-06 | PALISADE BIO, INC. | Jones Mitchell La...
(Chief Medical Officer) |
M | Common Stock, par value $0.01 | A | 6891 | $0.00 - $0.00 | $0 |
2024-02-06 | PALISADE BIO, INC. | Jones Mitchell La...
(Chief Medical Officer) |
F | Common Stock, par value $0.01 | D | 2153 | $0.44 - $0.44 | $938 |
2024-02-06 | PALISADE BIO, INC. | Finley John David
(CEO, CFO, Director) |
M | Common Stock, par value $0.01 | A | 6642 | $0.00 - $0.00 | $0 |
2024-02-06 | PALISADE BIO, INC. | Finley John David
(CEO, CFO, Director) |
P | Common Stock, par value $0.01 | A | 10000 | $0.47 - $0.47 | $4,692 |
2024-01-31 | PALISADE BIO, INC. | Finley John David
(CEO, CFO, Director) |
P | Common Stock, par value $0.01 | A | 10000 | $0.56 - $0.56 | $5,590 |
2024-01-31 | PALISADE BIO, INC. | Williams Donald A...
(Director) |
P | Common Stock, par value $0.01 | A | 10000 | $0.60 - $0.60 | $6,050 |
2023-12-11 | PALISADE BIO, INC. | Finley John David
(CEO, CFO, Director) |
M | Common Stock, par value $0.01 | A | 5559 | $0.00 - $0.00 | $0 |
2023-11-20 | PALISADE BIO, INC. | Finley John David
(CEO, CFO, Director) |
A | Common Stock, par value $0.01 | A | 10000 | $0.51 - $0.51 | $5,100 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |